首页> 外国专利> METHOD FOR IMPROVING OXYGENATING PULMONARY FUNCTION IN THE PATIENTS WITH A NEW CORONAVIRAL INFECTION (COVID-19) WITH RESPIRATORY FAILURE WHO ARE ON RESPIRATORY SUPPORT

METHOD FOR IMPROVING OXYGENATING PULMONARY FUNCTION IN THE PATIENTS WITH A NEW CORONAVIRAL INFECTION (COVID-19) WITH RESPIRATORY FAILURE WHO ARE ON RESPIRATORY SUPPORT

机译:有呼吸支持的新的冠心病感染(COVID-19)患者改善氧合肺功能的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to intensive care and resuscitation, and can be used for treating patients with a new coronavirus infection (COVID-19). Method involves intravenous introduction of a serotonin adipinate solution at rate of 10–30 mg/h to the patients with a new coronaviral infection COVID-19 with respiratory failure on respiratory support. Respiratory support is non-invasive lung ventilation, oxygen therapy; additionally, calcium nandroparin or enoxaparine are administered.;EFFECT: using the invention enables improving the oxygenating function of the lungs by normalizing smooth muscle function of the microcirculatory bed of the lungs and other organs, and thereby increasing gas exchange.;1 cl, 3 tbl, 3 ex
机译:技术领域本发明涉及医学,即重症监护和复苏,并且可以用于治疗患有新的冠状病毒感染(COVID-19)的患者。该方法涉及以10–30 mg / h的速率向患有新冠状病毒感染COVID-19并伴有呼吸支持的呼吸衰竭的患者静脉内注射5-羟色胺己二酸酯溶液。呼吸支持是无创肺通气,氧气治疗;效果:使用本发明能够通过使肺和其他器官的微循环床的平滑肌功能正常化并由此增加气体交换来改善肺的氧合作用。1 cl,3 tbl,3前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号